Skip to main content
Log in

Efficacy of oral methotrexate pulsed therapy in eales disease

  • Original Article
  • Published:
Annals of Ophthalmology

Abstract

A prospective study was undertaken to evaluate oral methotrexate pulsed therapy in 6 cases of Eales disease presenting with perivasculitis. Methotrexate was administered (7.5 mg weekly) for 3 months. The therapy was tolerated well, and retinal perivasculitis subsided in all cases. Five patients achieved excellent visual acuity—6/6 (20/20) or better. Elevated titers of C-reactive protein returned to normal after therapy. Six-month follow-up revealed no recurrence of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gieser SC, Murphy RP. Eales disease. In: Ryan SJ, ed. Retina. Vol 2: Medical retina. St Louis, Mo: Mosby-Year Book; 1994:1503–1507.

    Google Scholar 

  2. Kumar D, Saxena RC, Saxena S. Vitreous hemorrhage in Eales disease. Afro-Asian J Ophthalmol. 1995;13:109–112.

    Google Scholar 

  3. Saxena S, Kumar D, Singh VK, Rajasingh J. Immunological studies in Eales disease: a review. Afro-Asian J Ophthalmol. 1995;13:19–22.

    Google Scholar 

  4. Rengarajan K, Muthukkaruppan VR, Namperumalsamy P. Biochemical analysis of serum proteins from Eales' patients. Curr Eye Res. 1989;8:1259–1269.

    PubMed  CAS  Google Scholar 

  5. Muthukkaruppan VR, Rengarajan K, Chakkalath HR, Namperumalsamy P. Immunological status of patients of Eales' disease. Ind J Med Res. 1989;90:351–359.

    CAS  Google Scholar 

  6. Sawhney R, Gupta A, Bansal RK, et al. Eales' disease: an autoimmune retinal disorder. Proc All India Ophthalmol Soc. 1992;50:461–464.

    Google Scholar 

  7. Biswas J, Rao NA. Epiretinal membranes in Eales' disease and other vascular retinopathies. Invest Ophthalmol Vis Sci. 1990;31 (suppl):369.

    Google Scholar 

  8. Badrinath SS, Biswas J, Sharma T. et al. Immunophenotyping of inflammatory infiltrates in epiretinal (ERM) and subretinal (SRM) membranes in Eales' disease. Invest Ophthalmol Vis Sci. 1992;33 (suppl):857.

    Google Scholar 

  9. Chauber BA, Allegra CJ, Curt GA, Calabresi P. Antineoplastic agents. In: JG Mardman, Limbird LE. eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill; 1996:1233–1282.

    Google Scholar 

  10. Palmer HE, Stanford MR, Sanders MD, Graham EM. Visual outcome of patients with idiopathic ischaemic and non-ischaemic retinal vasculitis. Eye. 1996;10:343–348.

    PubMed  Google Scholar 

  11. Stanford MR, Graham EM, Kasp E, et al. A longitudinal study of clinical and immunological findings in 52 patients with relapsing retinal vasculitis. Br J Ophthalmol. 1988;72:442–447.

    PubMed  CAS  Google Scholar 

  12. Howe LJ, Stanford MR, Edelsten C, Graham EM. The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis. Eye. 1994;8:443–447.

    PubMed  Google Scholar 

  13. Isaacs J, Dick A. Short term immunosuppressive therapy and long term immunoregulation: promises and problems [commentary]. Br J Ophthalmol. 1996;80:1035–1036.

    PubMed  CAS  Google Scholar 

  14. Shah SS, Lowder CY, Schmitt MA, et al. Low-dose methotroxate therapy for ocular inflammatory disease. Ophthalmology. 1992;99:1419–1423.

    PubMed  CAS  Google Scholar 

  15. Meyer PA, Watson PG, Franks W, Dubord P. Pulsed immunosuppreasive therapy in the treatment of immunologically induced corneal and scleral disease. Eye. 1987;1:487–495.

    PubMed  Google Scholar 

  16. Mime CA, Playfair JHL, Roitt IMR, et al. The innate defenses of the body. In: Medical Microbiology. St Louis, Mo: Mosby-Year Book; 1993:4.1–4.14.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saxena, S., Kumar, D. & Kapoor, S. Efficacy of oral methotrexate pulsed therapy in eales disease. Ann Ophthalmol 32, 60–62 (2000). https://doi.org/10.1007/s12009-000-0014-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12009-000-0014-5

Keywords

Navigation